Richmond Pharmacology Ltd (RPL) is proud to announce that it recently celebrated its 10th anniversary in style with a quintessentially British day on the river at this year�s Henley Royal Regatta.  

The Henley Royal Regatta has been held annually since 1839 and remains one of Britain s most prestigious sporting events, and as such was a fitting place to hold this esteemed celebration.The day started off with an official welcome by RPL s co-founder and CEO, Dr Jorg Taubel, followed by a morning presentation by guest speaker, Dr Tony Soteriou, Deputy Director, Head of NHS Research Infrastructure and Industry R&D Relations from the Department of Health, looking at new initiatives to simplify the regulatory process for clinical research conducted in the United Kingdom.

After the morning presentation guests attended the prestigious Fawley Meadows Restaurant to relax and enjoy the afternoon s festivities.

Richmond Pharmacology was co-founded in August 2001 by RPL s three Executive Directors Dr Ulrike Lorch, Dr Radivoj Arezina and Dr J rg T ubel, and first opened at the Atkinson Morely Hospital in Wimbledon.  10 years on, now based in two of the UK s largest acute NHS teaching hospitals, RPL has undergone steady expansion and has since become one of Europe s leading full-service specialist early phase CROs. The first to obtain MHRA standard and supplementary accreditation for two hospital based clinical trial units coupled with its supreme expertise gained from over 500 early phase studies carried out to date, RPL is proud to be celebrating 10 years of clinical excellence, still leading the way as the experts in the field of early phase clinical research!

Latest news

Futureproofing early phase clinical research for the next generation of investigators.

March 20, 2023
Richmond Pharmacology’s experienced Principal investigators and Co-investigators recently gave expert feedback on the ICH M11 (CeSHarP) protocol template.
Read more

Director of Operations, Keith Berelowitz, has been appointed as the Research Ethics Committee Chair for the Health Research Authority.

January 19, 2023
Keith Berelowitz will be responsible for ensuring that all ethical possibilities are explored in relation to new research.
Read more

Events

13th International Workshop on Regulatory Requirements and Current Scientific Aspects on the Preclinical and Clinical Investigation of Drug-Drug Interactions

Sunday, June 4th to Tuesday June 6th 2023
Exchange research-based knowledge on drug-drug interactions (DDIs) among all interested stakeholders from pharmaceutical industry, regulatory authorities, academic and health care delivery backgrounds and perspectives.
View event